When a patient walks into a clinic—whether they are seeking a fertility treatment, a root canal, or urgent care for a sick pet—they are rarely shopping for a bargain. They are seeking a solution to a problem that often involves pain, anxiety, or a deep emotional longing. In these moments, the power imbalance between the provider and the consumer is at its peak.
As a physician, I have seen how the stress of a medical crisis can cloud a patient’s ability to parse complex pricing tiers or question a treatment plan. This inherent vulnerability is exactly what the Competition and Markets Authority (CMA) is now targeting. The regulator is shifting its gaze from broad market competition toward a more surgical focus on consumer protection, specifically in sectors where “essential spend” meets limited transparency.
Recent actions by the CMA, coupled with the rollout of the Digital Markets, Competition and Consumers (DMCC) Act 2024, signal a new era of enforcement. The goal is no longer just to ensure that companies compete, but to ensure that consumers are not preyed upon through “drip pricing,” misleading reviews, or opaque membership fees during their most vulnerable moments.
The £8 Billion Shift in Private Dentistry
The most pressing front in this regulatory battle is the UK’s private dentistry market. On March 5, 2026, the CMA launched a sweeping investigation into a sector now estimated to be worth £8 billion. The growth of this market has not happened in a vacuum; This proves the direct result of a tightening squeeze on NHS dental access, forcing thousands of patients into the private sector out of necessity rather than choice.
The timing of the investigation is critical. It coincides with the April 1, 2026, implementation of NHS dentistry contract reforms. As the public system undergoes a structural overhaul, the CMA is concerned that the private market may capitalize on the resulting instability. Patients are already reporting sharp increases in treatment costs and a confusing array of pricing models that make it nearly impossible to compare services across practices.
The CMA’s investigation is specifically dissecting the “consumer journey.” So looking beyond the final bill to examine how options are presented to patients. The regulator is asking whether patients are being given a genuine choice of treatments or if they are being steered toward higher-cost procedures without adequate transparency. For practitioners, the message is clear: the “professional diligence” standard applied to fertility clinics—which mandates strict guidelines on information provision and fair pricing—is likely coming to the dental chair next.
Closing the Loop on Veterinary Care
While the dentistry probe is just beginning, the CMA has already brought its review of the veterinary services market for household pets to a close. The final report, issued March 24, 2026, painted a stark picture of a market where pet owners often paid premiums simply because they lacked the information to shop around.
The resulting reforms, set for full implementation by the end of 2026, target the most frustrating “hidden” costs of pet ownership. A key victory for consumers is the new cap on fees for written prescriptions, now limited to £21. This prevents practices from charging exorbitant fees for a simple administrative task, allowing owners to seek more affordable medication options elsewhere.
To solve the information gap, the CMA is enhancing the “Find a Vet” website with new comparative features. This allows owners to weigh practices against one another based on transparent data rather than anecdotal evidence. The CMA has pushed the government to grant the Royal College of Veterinary Surgeons (RCVS) stronger enforcement powers. This shift moves the needle from “guidelines” to “requirements,” giving the regulator the teeth to penalize businesses and professionals who fail to meet transparency standards.
| Sector | Primary Consumer Pain Point | Key Regulatory Intervention | Status/Timeline |
|---|---|---|---|
| Private Dentistry | Opaque pricing; NHS access gaps | Market study on patient journey & pricing | Investigation launched March 2026 |
| Veterinary Services | Limited choice; hidden premiums | £21 prescription cap; RCVS enforcement | Reforms by end of 2026 |
| Digital Services | “Subscription traps”; auto-renewals | Strict disclosure & cancellation rules | Secondary legislation Spring 2027 |
Digital Traps and the DMCC Act
Consumer protection is not limited to the clinic or the vet’s office. The government is extending these protections into the digital realm via the Digital Markets, Competition and Consumers (DMCC) Act 2024. While much of the Act is already active, a critical piece regarding digital subscription contracts has been deferred to secondary legislation.
On April 2, 2026, the government confirmed that these specific provisions are expected to come into force by Spring 2027. The scale of the problem is staggering: it is estimated that the public spends £400 million annually on “unwanted” or “misleading” subscriptions. These are often the result of “dark patterns”—design choices that make it easy to sign up for a free trial but nearly impossible to cancel before a high-rate auto-renewal kicks in.
Under the new rules, a “digital subscription” (defined as a contract for goods, services, or digital content in exchange for payment) will be subject to rigorous communication requirements. Suppliers will be mandated to ensure consumers are fully informed of terms before signing up and will be required to send reminders before a trial ends or a contract renews. This effectively ends the era of the “silent renewal,” shifting the burden of clarity from the consumer to the trader.
The Common Thread: Vulnerability
Whether it is a pet owner facing a sudden surgery, a patient struggling with infertility, or a consumer caught in a digital subscription loop, the common thread is the exploitation of a “blind spot.” The CMA is increasingly recognizing that in essential markets, a lack of information is not just a market failure—it is a consumer protection failure.
For healthcare providers, this means a shift in operational philosophy. Proactive transparency—clear, written pricing, honest communication about treatment alternatives, and simplified billing—is no longer just a “best practice” for patient satisfaction. It is becoming a regulatory requirement to avoid the scrutiny of the CMA.
Disclaimer: This article is provided for informational purposes only and does not constitute legal or medical advice. For specific regulatory guidance, please consult the official CMA guidelines or a qualified legal professional.
The next major milestone for consumer protection will be the rollout of the DMCC secondary legislation in Spring 2027, which will formally codify the rules for digital subscriptions. Until then, the industry will be watching the private dentistry investigation closely to see how the CMA defines “fair pricing” in a market under pressure.
Do you feel that private healthcare pricing in the UK has become too opaque? Share your experiences in the comments or share this article to start the conversation.
